• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0
×

Target

Host

Species Reactivity

Species Reactivity

Conjugate

Conjugate

FITC Plus Anti-Human CD8 (UCHT4) Rabbit Recombinant Antibody

CD8 Recombinant Antibody for FC

Host / Isotype

Rabbit / IgG

Reactivity

Human

Applications

FC

Conjugate

FITC Plus Fluorescent Dye

CloneNo.

UCHT4

Cat no : FITC-65510

Synonyms

CD8, CD8A, CD8a molecule, Leu2, MAL, p32

Validation Data Gallery

Filter:
  • Flow cytometry (FC) experiment of human PBMCs using FITC Plus Anti-Human CD8 (UCHT4) Rabbit Recombinan (FITC-65510)

    FC experiment of human PBMCs using FITC-65510

    1x10^6 human PBMCs were surface stained with CL750 Anti-Human CD3 and 5 ul FITC Plus Anti-Human CD8 Rabbit Recombinant Antibody (FITC-65510, Clone:UCHT4) or FITC-conjugated Rabbit IgG control PolyAb (FITC-30000). Cells were not fixed. Lymphocytes were gated.

  • Flow cytometry (FC) experiment of human PBMCs using FITC Plus Anti-Human CD8 (UCHT4) Rabbit Recombinan (FITC-65510)

    FC experiment of human PBMCs using FITC-65510

    1x10^6 human PBMCs were surface stained with 5 ul FITC Plus Anti-Human CD8 Rabbit Recombinant Antibody (FITC-65510, Clone:UCHT4) or FITC-conjugated Rabbit IgG control PolyAb (FITC-30000). Cells were not fixed. Lymphocytes were gated.

  • Flow cytometry (FC) experiment of human PBMCs using FITC Plus Anti-Human CD8 (UCHT4) Rabbit Recombinan (FITC-65510)

    FC experiment of human PBMCs using FITC-65510

    1x10^6 human PBMCs were surface stained with CL750 Anti-Human CD3 and 5 ul FITC Plus Anti-Human CD8 Rabbit Recombinant Antibody (FITC-65510, Clone:UCHT4) (left) or 5 ul FITC Plus Anti-Human CD8 Mouse Monoclonal Antibody (FITC-65204, Clone:UCHT4) (right). Cells were not fixed. Lymphocytes were gated.

☆大好評トライアルサイズ ¥20,000～！ >>> 一次抗体特別価格キャンペーン開催中！

Tested Applications

Positive FC detected inhuman PBMCs

Recommended dilution

ApplicationDilution
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 µl per 10^6 cells in a 100 µl suspension or 5 µl per 100 µl of whole blood.
Sample-dependent, Check data in validation data gallery.

Product Information

FITC-65510 targets CD8 in FC applications and shows reactivity with Human samples.

Tested Reactivity Human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen Thymocytes and Sézary T cells 相同性解析による交差性が予測される生物種
Full Name CD8a molecule
Calculated molecular weight 235 aa, 26 kDa
GenBank accession numberBC025715
Gene symbol CD8A
Gene ID (NCBI) 925
Conjugate FITC Plus Fluorescent Dye
Excitation/Emission maxima wavelengths495 nm / 524 nm
Form Liquid
Purification MethodAffinity purification
Storage Buffer PBS with 0.09% sodium azide and 0.5% BSA.
Storage ConditionsStore at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

Background Information

CD8 is a transmembrane glycoprotein composed of two disulfide-linked chains. It can be present as a homodimer of CD8α or as a heterodimer of CD8α and CD8β (PMID: 3264320; 8253791). CD8 is found on most thymocytes. The majority of class I-restricted T cells express mostly the CD8αβ heterodimer while CD8αα homodimers alone have been found on some gut intraepithelial T cells , on some T cell receptor (TCR) γδ T cells and on NK cells (PMID: 2111591; 1831127; 8420975). CD8 acts as a co-receptor that binds to MHC class-I and participates in cytotoxic T cell activation (PMID: 8499079). During T cell development, CD8 is required for positive selection of CD4-/CD8+ T cells (PMID: 1968084).

Protocols

Product Specific Protocols
FC protocol for FITC Plus CD8 antibody FITC-65510Download protocol
Standard Protocols
Click here to view our Standard Protocols